
Lipotek Pharmaceuticals Private Limited
About Lipotek Pharmaceuticals Private Limited
Data last updated:
Lipotek Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 17 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2016PTC104180. Its GSTIN is 33AADCL0190J1ZP (Tamil Nadu).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Ramaswamy Balasubramani and Nagendiran.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.1 Thangalkarai Street Mgr Nagar Chitlapakkam, Chennai, Tamil Nadu, India – 600064.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.8 Lakh, a growth of 26% compared to the previous year. For the same year it recorded a net loss of ₹9,346 (net margin -0.3%) and EBITDA of -₹7,470 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lipotek Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.1 Thangalkarai Street Mgr Nagar Chitlapakkam, Chennai, Tamil Nadu, India – 600064
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Lipotek Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lipotek Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lipotek Pharmaceuticals Private Limited, buy the company report.
Financials of Lipotek Pharmaceuticals Private Limited
FY 2025 filings availableLipotek Pharmaceuticals Private Limited reported revenue of ₹36.8 Lakh (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 26% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7,470 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9,346 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lipotek Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lipotek Pharmaceuticals Private Limited
Lipotek Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramaswamy Balasubramani | Director | 17 Feb 2016 | 10 Years 8 Months | Current |
| Nagendiran | Director | 17 Feb 2016 | 10 Years 8 Months | Current |
Peer comparison
Lipotek Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BLJ Pharmaceuticals Private Limited | ₹37.07 Lakh (FY 2025) | 1530.0% | Dadri, Uttar Pradesh, India | |||
| Ashi Pharmaceuticals Private Limited | ₹36.95 Lakh (FY 2019) | -11.0% | Indore, Madhya Pradesh, India | |||
| Lipotek Pharmaceuticals Private Limitedthis company | ₹36.8 Lakh (FY 2025) | -₹9,346 | -0.3% | 26.0% | Chennai, Tamil Nadu, India | |
| Sun Eye Care Pharmaceuticals Private Limited | ₹36.68 Lakh (FY 2025) | -9.0% | Moradabad, Uttar Pradesh, India | |||
| Beactive Pharmaceuticals Private Limited | ₹36.65 Lakh (FY 2024) | 85.0% | Ambala, Haryana, India |
To see the full peer comparison of Lipotek Pharmaceuticals Private Limited, buy the company report.
Auditor
Lipotek Pharmaceuticals Private Limited is audited by S.AMMAIAPPAN for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.AMMAIAPPAN | FY 2017 | 020396 |
Shareholding
The shareholding of Lipotek Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Lipotek Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lipotek Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lipotek Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lipotek Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCL0190J1ZP | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lipotek Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lipotek Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Nagendiran was appointed as Director on 17 Feb 2016.
Frequently asked questions
Lipotek Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in retailers, within the trading industry. It was incorporated on 17 February 2016 (10+ years old) and is registered under CIN U51909TN2016PTC104180.
Lipotek Pharmaceuticals has 2 current directors:
- Ramaswamy Balasubramani - Director
- Nagendiran - Director
The latest financial statements of Lipotek Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Lipotek Pharmaceuticals is 33AADCL0190J1ZP, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Lipotek Pharmaceuticals is U51909TN2016PTC104180. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lipotek Pharmaceuticals was incorporated on 17 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Lipotek Pharmaceuticals by revenue are BLJ Pharmaceuticals Private Limited, Ashi Pharmaceuticals Private Limited, Sun Eye Care Pharmaceuticals Private Limited, Beactive Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Nagendiran was appointed as Director on 17 Feb 2016. Ramaswamy Balasubramani was appointed as Director on 17 Feb 2016.
The registered office of Lipotek Pharmaceuticals is at No.1 Thangalkarai Street Mgr Nagar Chitlapakkam, Chennai, Tamil Nadu, India – 600064.
Lipotek Pharmaceuticals operates in the trading industry, in the retailers segment.
The compliance status of Lipotek Pharmaceuticals is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.

